(41, 42) synthesized poly(β-L-malic acid) (PMLA)-based nano bioconjugates, capable of crossing the BBB via transferrin receptor (TfR)-mediated pinocytosis to target brain tumors. Here, TFRC is linked to brain neoplasm.